Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Roots to Thrive is a non-profit healthcare organization based in British Columbia, Canada, dedicated to providing psychedelic-assisted therapy within a community-supported model. The society is recognized for pioneering the first legal community-based ketamine-assisted therapy program in Canada and has expanded to include psilocybin-assisted treatments for patients with end-of-life distress and treatment-resistant conditions. Their clinical model emphasizes a multidisciplinary approach, combining medical oversight with psychological support and peer-group integration. Roots to Thrive works in collaboration with Vancouver Island University and local health authorities to conduct research and establish best practices for psychedelic medicine. The organization focuses on treating complex mental health challenges, including PTSD, depression, and anxiety, while advocating for broader patient access through regulatory channels like Health Canada's Special Access Program.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Roots to Thrive Society for Psychedelic Therapy.